Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 16, 2013
Showing 1-1 of 1
Last Updated: 09/26/2026